Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy.

Authors:
Choo S; Wolf CB; Mack HM; Egan MJ; Kiem HP and 1 more

Journal:
Blood Adv

Publication Year: 2024

DOI:
10.1182/bloodadvances.2023011371

PMCID:
PMC10877116

PMID:
38113461

Journal Information

Full Title: Blood Adv

Abbreviation: Blood Adv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest disclosure: S.R. is a consultant or has ownership interests with 48 Bio, Inc, Proteios Technology Inc, and Ensoma Inc. H.-P.K. is, or was, a consultant to, and has, or had, ownership interests with, Rocket Pharmaceuticals, Homology Medicines, Vor Biopharma, and Ensoma Inc, and has been a consultant to CSL Behring and Magenta Therapeutics. The remaining authors declare no competing financial interests."

Evidence found in paper:

"This work was supported by the 10.13039/100000865Gates Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025